Toronto Dominion Bank
PACB icon

Toronto Dominion Bank’s Pacific Biosciences PACB Stock Holding History

Toronto Dominion Bank’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-500,100
Closed -$590K – 1946
2025
Q1 		$590K Sell
500,100
-349,900
-41% -$537K ﹤0.01% 1140
2024
Q4 		$1.56M Buy
+850,000
New +$1.66M ﹤0.01% 982

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Toronto Dominion Bank's PACB Position: Q2 2025 in Review

Toronto Dominion Bank sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 500,100 shares — an estimated $590K sold.

Toronto Dominion Bank first reported a position in PACB in Q4 2024 and held it in 2 quarters. The position peaked at $1.56M in Q4 2024. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • Toronto Dominion Bank reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 500,100 Pacific Biosciences shares in Q2 2025, an estimated $590K.
  • Toronto Dominion Bank first reported a position in Pacific Biosciences in Q4 2024 and held it in 2 quarters.
  • Toronto Dominion Bank's Pacific Biosciences position peaked at $1.56M in Q4 2024.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on Toronto Dominion Bank's 13F filing for Q2 2025, filed 14 Aug 2025.